{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T14:21:24Z","timestamp":1790000484587,"version":"4.0.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"31","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.vaccine.2012.04.084","type":"journal-article","created":{"date-parts":[[2012,5,8]],"date-time":"2012-05-08T04:56:25Z","timestamp":1336452985000},"page":"4681-4690","source":"Crossref","is-referenced-by-count":58,"title":["An agonist of human complement fragment C5a enhances vaccine immunity against Coccidioides infection"],"prefix":"10.1016","volume":"30","author":[{"given":"Chiung-Yu","family":"Hung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brady J.","family":"Hurtgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Bellecourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam D.","family":"Sanderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward L.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garry T.","family":"Cole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2012.04.084_bib0005","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1086\/496991","article-title":"Coccidioidomycosis","volume":"41","author":"Galgiani","year":"2005","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.vaccine.2012.04.084_bib0010","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1101\/gr.087551.108","article-title":"Comparative genomic analyses of the human fungal pathogens Coccidioides and their relatives","volume":"19","author":"Sharpton","year":"2009","journal-title":"Genome Research"},{"key":"10.1016\/j.vaccine.2012.04.084_bib0015","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.3390\/ijerph8041150","article-title":"The public health impact of coccidioidomycosis in Arizona and California","volume":"8","author":"Hector","year":"2011","journal-title":"International Journal of Environmental Research and Public Health"},{"key":"10.1016\/j.vaccine.2012.04.084_bib0020","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/13693780410001687349","article-title":"A vaccine against coccidioidomycosis is justified and attainable","volume":"42","author":"Cole","year":"2004","journal-title":"Medical Mycology"},{"key":"10.1016\/j.vaccine.2012.04.084_bib0025","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.3201\/eid1611.100475","article-title":"Enhanced surveillance of coccidioidomycosis, Arizona, USA, 2007\u20132008","volume":"16","author":"Tsang","year":"2010","journal-title":"Emerging Infectious Diseases"},{"key":"10.1016\/j.vaccine.2012.04.084_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/fgbi.2000.1243","article-title":"Seeking a vaccine against Coccidioides immitis and serologic studies: expectations and realities","volume":"32","author":"Pappagianis","year":"2001","journal-title":"Fungal Genetics and Biology"},{"key":"10.1016\/j.vaccine.2012.04.084_bib0035","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1172\/JCI43984","article-title":"Vaccine-induced protection against 3 systemic mycoses endemic to North America requires Th17 cells in mice","volume":"121","author":"W\u00fcthrich","year":"2011","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.vaccine.2012.04.084_bib0040","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.1128\/IAI.05726-11","article-title":"Vaccine immunity to coccidioidomycosis occurs by early activation of three signal pathways of T helper cell response (Th1, Th2 and Th17)","volume":"79","author":"Hung","year":"2011","journal-title":"Infection and Immunity"},{"key":"10.1016\/j.vaccine.2012.04.084_bib0045","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1023\/A:1007081707287","article-title":"Murine models of blastomycosis, coccidioidomycosis, and histoplasmosis","volume":"146","author":"Sorensen","year":"1999","journal-title":"Mycopathologia"},{"key":"10.1016\/j.vaccine.2012.04.084_bib0050","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1128\/IAI.40.3.912-916.1983","article-title":"Inbred mouse strains differ in resistance to lethal Coccidioides immitis infection","volume":"40","author":"Kirkland","year":"1983","journal-title":"Infection and Immunity"},{"key":"10.1016\/j.vaccine.2012.04.084_bib0055","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1128\/IAI.00459-09","article-title":"A genetically engineered live attenuated vaccine of Coccidioides posadasii protects BALB\/c mice against coccidioidomycosis","volume":"77","author":"Xue","year":"2009","journal-title":"Infection and Immunity"},{"key":"10.1016\/j.vaccine.2012.04.084_bib0060","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.vaccine.2009.10.029","article-title":"Enhancement of in vivo and in vitro immune functions by a conformationally biased, response-selective agonist of human C5a: implications for a novel adjuvant in vaccine design","volume":"28","author":"Morgan","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.04.084_bib0065","doi-asserted-by":"crossref","first-page":"8275","DOI":"10.1016\/j.vaccine.2010.10.008","article-title":"A novel adjuvant for vaccine development in the aged","volume":"28","author":"Morgan","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.04.084_bib0070","doi-asserted-by":"crossref","first-page":"675","DOI":"10.2174\/0929867013373156","article-title":"Development of response-selective agonists of human C5a anaphylatoxin: conformational, biological, and therapeutic considerations","volume":"8","author":"Taylor","year":"2001","journal-title":"Current Medicinal Chemistry"},{"key":"10.1016\/j.vaccine.2012.04.084_bib0075","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1016\/S1567-5769(01)00141-2","article-title":"Differential activities of decapeptide agonists of human C5a: the conformational effects of backbone N-methylation","volume":"1","author":"Vogen","year":"2001","journal-title":"International Immunopharmacology"},{"key":"10.1016\/j.vaccine.2012.04.084_bib0080","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.intimp.2008.01.031","article-title":"A conformationally-biased, response-selective agonist of C5a acts as a molecular adjuvant by modulating antigen processing and presentation activities of human dendritic cells","volume":"8","author":"Hegde","year":"2008","journal-title":"International Immunopharmacology"},{"key":"10.1016\/j.vaccine.2012.04.084_bib0085","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1016\/j.vaccine.2009.02.105","article-title":"Immune responses to methamphetamine by active immunization with peptide-based, molecular adjuvant-containing vaccines","volume":"27","author":"Duryee","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.04.084_bib0090","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S1567-5769(02)00260-6","article-title":"Immunization to nicotine with a peptide-based vaccine composed of a conformationally biased agonist of C5a as a molecular adjuvant","volume":"3","author":"Sanderson","year":"2003","journal-title":"International Immunopharmacology"},{"key":"10.1016\/j.vaccine.2012.04.084_bib0095","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1021\/bc9002794","article-title":"Single-step conjugation of bioactive peptides to proteins via a self-contained succinimidyl bis-arylhydrazone","volume":"20","author":"Phillips","year":"2009","journal-title":"Bioconjugate Chemistry"},{"key":"10.1016\/j.vaccine.2012.04.084_bib0100","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.micpath.2011.03.013","article-title":"Nitric oxide synthase activity has limited influence on the control of Coccidioides infection in mice","volume":"51","author":"Gonzalez","year":"2011","journal-title":"Microbial Pathogenesis"},{"key":"10.1016\/j.vaccine.2012.04.084_bib0105","first-page":"1039","article-title":"In vitro whole-blood analysis of cellular immunity in patients with active coccidioidomycosis by using the antigen preparation T27K","volume":"9","author":"Ampel","year":"2002","journal-title":"Clinical and Diagnostic Laboratory Immunology"},{"key":"10.1016\/j.vaccine.2012.04.084_bib0110","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0092-8674(00)80702-3","article-title":"A novel transcription factor, T-bet, directs Th1 lineage commitment","volume":"100","author":"Szabo","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2012.04.084_bib0115","doi-asserted-by":"crossref","first-page":"21597","DOI":"10.1074\/jbc.272.34.21597","article-title":"Transcription factor Gata-3 is differentially expressed in murine Th1 and Th2 cells and controls Th2-specific expression of the Interleukin-5 gene","volume":"272","author":"Zhang","year":"1997","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.vaccine.2012.04.084_bib0120","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.immuni.2007.11.016","article-title":"T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR\u03b1 and ROR\u03b3","volume":"28","author":"Yang","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2012.04.084_bib0125","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/ni.1760","article-title":"Foxp3+ regulatory T cells: differentiation, specification, subphenotypes","volume":"10","author":"Feuerer","year":"2009","journal-title":"Nature Immunology"},{"key":"10.1016\/j.vaccine.2012.04.084_bib0130","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.1016\/j.vaccine.2005.01.147","article-title":"Immune response of vaccinated and non-vaccinated mice to Coccidioides posadasii infection","volume":"23","author":"Xue","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.04.084_bib0135","doi-asserted-by":"crossref","first-page":"5341","DOI":"10.1128\/IAI.00845-10","article-title":"Interleukin-17 is not required for classical macrophage activation in a pulmonary mouse model of Cryptococcus neoformans infection","volume":"78","author":"Hardison","year":"2011","journal-title":"Infection and Immunity"},{"key":"10.1016\/j.vaccine.2012.04.084_bib0140","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1128\/IAI.69.5.2878-2887.2001","article-title":"Recombinant urease and urease DNA of Coccidioides immitis elicit an immunoprotective response against coccidioidomycosis in mice","volume":"69","author":"Li","year":"2001","journal-title":"Infection and Immunity"},{"key":"10.1016\/j.vaccine.2012.04.084_bib0145","doi-asserted-by":"crossref","first-page":"6689","DOI":"10.1128\/IAI.73.10.6689-6703.2005","article-title":"A metalloproteinase of Coccidioides posadasii contributes to evasion of host detection","volume":"73","author":"Hung","year":"2005","journal-title":"Infection and Immunity"},{"key":"10.1016\/j.vaccine.2012.04.084_bib0150","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.immuni.2010.10.002","article-title":"Vaccine adjuvants: putting innate immunity to work","volume":"33","author":"Coffman","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2012.04.084_bib0155","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/icb.2010.117","article-title":"Antigen-driven T-cell repertoire selection during adaptive immune responses","volume":"89","author":"Baumgartner","year":"2011","journal-title":"Immunology and Cell Biology"},{"key":"10.1016\/j.vaccine.2012.04.084_bib0160","doi-asserted-by":"crossref","first-page":"e1000703","DOI":"10.1371\/journal.ppat.1000703","article-title":"Th1-Th17 cells mediate protective adaptive immunity against Staphylococcus aureus and Candida albicans infection in mice","volume":"5","author":"Lin","year":"2009","journal-title":"PLoS Pathogens"},{"key":"10.1016\/j.vaccine.2012.04.084_bib0165","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1128\/IAI.66.5.2342-2345.1998","article-title":"Protection against lethal murine coccidioidomycosis by a soluble vaccine from spherules","volume":"66","author":"Zimmermann","year":"1998","journal-title":"Infection and Immunity"},{"key":"10.1016\/j.vaccine.2012.04.084_bib0170","series-title":"Fungal pathogenesis: principles and applications","first-page":"365","article-title":"Coccidioidomycosis pathogenesis, immune response and vaccine development","author":"Kirkland","year":"2002"},{"key":"10.1016\/j.vaccine.2012.04.084_bib0175","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2174\/1570162033485195","article-title":"Advances in vaccine adjuvants for infectious diseases","volume":"1","author":"Singh","year":"2003","journal-title":"Current HIV Research"},{"key":"10.1016\/j.vaccine.2012.04.084_bib0180","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1128\/IAI.67.6.2935-2940.1999","article-title":"Resistance to Coccidioides immitis in mice after immunization with recombinant protein or a DNA vaccine of a proline-rich antigen","volume":"67","author":"Abuodeh","year":"1999","journal-title":"Infection and Immunity"},{"key":"10.1016\/j.vaccine.2012.04.084_bib0185","doi-asserted-by":"crossref","first-page":"973","DOI":"10.3109\/02770903.2011.619288","article-title":"A prophylactic effect of an oligodeoxynucleotide containing a cytidine-guanosine motif against Japanese cedar pollen-induced T-helper type 2 allergic response","volume":"48","author":"Liu","year":"2011","journal-title":"Journal of Asthma"},{"key":"10.1016\/j.vaccine.2012.04.084_bib0190","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1128\/CMR.17.4.804-839.2004","article-title":"Coccidioidomycosis host response and vaccine development","volume":"17","author":"Cox","year":"2004","journal-title":"Clinical Microbiology Reviews"},{"key":"10.1016\/j.vaccine.2012.04.084_bib0195","doi-asserted-by":"crossref","first-page":"3966","DOI":"10.1128\/IAI.05493-11","article-title":"Neutrophils produce interleukin 17a (IL-17a) in a dectin-1- and IL-23-dependent manner during invasive fungal infection","volume":"79","author":"Werner","year":"2011","journal-title":"Infection and Immunity"},{"key":"10.1016\/j.vaccine.2012.04.084_bib0200","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.it.2007.03.008","article-title":"Duration, combination and timing: the signal integration model of dendritic cell activation","volume":"28","author":"Macagno","year":"2007","journal-title":"Trends in Immunology"},{"key":"10.1016\/j.vaccine.2012.04.084_bib0205","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00164-10","article-title":"Robust stimulation of humoral and cellular immune responses following vaccination with antigen-loaded \u03b2-glucan particles","volume":"1","author":"Huang","year":"2010","journal-title":"mBio"},{"key":"10.1016\/j.vaccine.2012.04.084_bib0210","doi-asserted-by":"crossref","first-page":"6058","DOI":"10.4049\/jimmunol.0804186","article-title":"Dendritic cell function in allostimulation is modulated by C5aR signaling","volume":"183","author":"Peng","year":"2009","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.vaccine.2012.04.084_bib0215","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1471-2172-11-60","article-title":"In vivo trafficking and immunostimulatory potential of an intranasally-administered primary dendritic cell-based vaccine","volume":"11","author":"Vilekar","year":"2010","journal-title":"BMC Immunology"},{"key":"10.1016\/j.vaccine.2012.04.084_bib0220","doi-asserted-by":"crossref","first-page":"e27289","DOI":"10.1371\/journal.pone.0027289","article-title":"Up-regulation of Th 17 cells may underlie inhibition of Treg development caused by immunization with activated syngeneic T cells","volume":"6","author":"Wang","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2012.04.084_bib0225","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1006\/clin.1997.4420","article-title":"IL-6: insights into novel biological activities","volume":"85","author":"Barton","year":"1997","journal-title":"Clinical Immunology and Immunopathology"},{"key":"10.1016\/j.vaccine.2012.04.084_bib0230","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1365-2567.2009.03240.x","article-title":"Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease","volume":"129","author":"Onishi","year":"2010","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2012.04.084_bib0235","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1002\/eji.201040539","article-title":"IFN-\u03b3 and IL-12 synergize to convert in vivo generated Th17 into Th1\/Th17 cells","volume":"40","author":"Lexberg","year":"2010","journal-title":"European Journal of Immunology"},{"key":"10.1016\/j.vaccine.2012.04.084_bib0240","doi-asserted-by":"crossref","first-page":"5848","DOI":"10.1128\/IAI.67.11.5848-5853.1999","article-title":"Coadministration of interleukin 12 expression vector with antigen 2 cDNA enhances induction of protective immunity against Coccidioides immitis","volume":"67","author":"Jiang","year":"1999","journal-title":"Infection and Immunity"},{"key":"10.1016\/j.vaccine.2012.04.084_bib0245","doi-asserted-by":"crossref","first-page":"14292","DOI":"10.1073\/pnas.1009234107","article-title":"Proinflammatory T helper type 17 cells are effective B-cell helpers","volume":"107","author":"Mitsdoerffer","year":"2010","journal-title":"PNAS"},{"key":"10.1016\/j.vaccine.2012.04.084_bib0250","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1146\/annurev-immunol-020711-074958","article-title":"Adaptive immunity to fungi","volume":"30","author":"Wuthrich","year":"2012","journal-title":"Annual Review of Immunology"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12006305?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12006305?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,7]],"date-time":"2020-07-07T07:36:34Z","timestamp":1594107394000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X12006305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":50,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0264410X12006305"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.04.084","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}